Steward Partners Investment Advisory’s Global Cord Blood Corporation CO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-150
| Closed | -$158 | – | 3495 |
|
|
2023
Q2 | $158 | Buy |
+150
| New | +$158 | ﹤0.01% | 3251 |
|
|
2022
Q4 | – | Sell |
-150
| Closed | – | – | 3533 |
|
|
2022
Q3 | $0 | Sell |
150
-3,239
| -96% | -$7.96K | ﹤0.01% | 3508 |
|
|
2022
Q2 | $10K | Hold |
3,389
| – | – | ﹤0.01% | 2534 |
|
|
2022
Q1 | $13K | Hold |
3,389
| – | – | ﹤0.01% | 2574 |
|
|
2021
Q4 | $14K | Buy |
3,389
+3,089
| +1,030% | +$13.1K | ﹤0.01% | 2488 |
|
|
2021
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 3135 |
|
|
2021
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 6919 |
|
|
2021
Q1 | $1.36K | Hold |
300
| – | – | ﹤0.01% | 3276 |
|
|
2020
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 2856 |
|
|
2020
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 2721 |
|
|
2020
Q2 | $1K | Hold |
300
| – | – | ﹤0.01% | 2645 |
|
|
2020
Q1 | $0 | Hold |
300
| – | – | ﹤0.01% | 2837 |
|
|
2019
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 2567 |
|
|
2019
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 2593 |
|
|
2019
Q2 | $1K | Buy |
+300
| New | +$1.98K | ﹤0.01% | 2594 |
|
|
2018
Q4 | – | Sell |
-300
| Closed | -$2K | – | 2583 |
|
|
2018
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 2452 |
|
|
2018
Q2 | $3K | Hold |
300
| – | – | ﹤0.01% | 2183 |
|
|
2018
Q1 | $3K | Buy |
+300
| New | +$3.06K | ﹤0.01% | 1976 |
|
Other funds holding CO
Steward Partners Investment Advisory's CO Position: Q3 2023 in Review
Steward Partners Investment Advisory sold out of Global Cord Blood Corporation (CO) in Q3 2023, closing a stake of 150 shares — an estimated $158 sold.
Steward Partners Investment Advisory first reported a position in CO in Q1 2018 and held it in 18 quarters. The position peaked at $14K in Q4 2021. 2 funds tracked by Wall St. Rank hold CO as of Q3 2023.
- Steward Partners Investment Advisory reported no remaining Global Cord Blood Corporation position as of Q3 2023 after selling out during the quarter.
- Steward Partners Investment Advisory sold 150 Global Cord Blood Corporation shares in Q3 2023, an estimated $158.
- Steward Partners Investment Advisory first reported a position in Global Cord Blood Corporation in Q1 2018 and held it in 18 quarters.
- Steward Partners Investment Advisory's Global Cord Blood Corporation position peaked at $14K in Q4 2021.
- 2 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2023.
Based on Steward Partners Investment Advisory's 13F filing for Q3 2023, filed 13 Nov 2023.